European Information Network - Ethics in Medicine and Biotechnology
A project of the European Commission,Quality of Life and Management of Living Resources Programme
|
|
European Information Network - Ethics in Medicine and BiotechnologyA project of the European Commission,Quality of Life and Management of Living Resources Programme |
| Eureth.net Home | News | Events | Literature | Partners | Topics | Links | ENDEBIT | EUROETHICS | Thesaurus |
| DRZEs Eurethnet-Home | Contact us |
If you require further information, please contact the organizers directly.
| Back to calendar |
|
| Date: | 08.03.2004 |
| Location: | Queen Elizabeth II Conference Centre, London, UK London United Kingdom |
| Keywords: | Pharmaceutics/drugs |
| Details: | The 8th Annual International Conference & Exhibition is the premier, European-based event reviewing the entire drug discovery process. Drug Discovery Technology® Europe combines the latest technologies and real scientific data with a thorough analysis of current business strategies and trends in drug discovery and development. In addition to the focused scientific programmes, this 3 day event will also include an associated exhibition showcasing technology and service providers from all sectors of the drug discovery and development industry. The exhibition programme will include: * Over 70 exhibiting companies * Poster presentations * Focused Networking Activities * Lunchtime discussions * Technology Tutorials and New Product Demonstrations Now in its 8th year Drug Discovery Technology® Europe returns to London, enabling unprecedented access to global pharmaceutical companies, key biotechnology clusters, leading academic and medical research institutes. The UK remains the dominant player within Europe for biotechnology, accounting for 37% (?2.9 Billion) of the total European revenue, with 45% of public companies in this sector located in the UK*. An analysis of the world's top 100 medicines, also reveals that, after the USA, Britain's pharmaceutical companies market share is easily more than all its European competitors combined. Venture capital investment in the biotechnology sector remains strong, at its third highest year ever. Biotech companies received 26% of all European capital investment in 2002, the joint highest proportion along with the software sector*. More European biotech companies are on the verge of profitability than ever before. A potential tidal wave of product successes is building up, which could transform the industry. This year's unique event format, targets the information needs of the entire drug discovery and development community. The event consists of: * three dedicated scientific conferences providing detailed knowledge on key industry bottlenecks * a series of critical business strategy workshops and seminars * a plenary session providing an informative industry update |
| Contact: | Dr Lindsay Aspinwall, Sanjay Singh, Elaine Crehan Address: Tel: +44 (0)20 7017 5396, +44 (0)20 7017 5181, +44 (0)20 7017 5758 Fax: +44 (0)20 7017 5656 Email: lindsay.aspinwall@informa.com; sanjay.singh@informa.com; elaine.crehan@informa.com |
| Webpage: | http://www.drugdisc.com/europe |
| Eureth.net Home | News | Events | Literature | Partners | Topics | Links | ENDEBIT | EUROETHICS | Thesaurus |
| EURETHNET site at © DRZE: last update 21.05.2008 General information | Administration: webmaster@drze.de |